[Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment].

S I Gavrilova,I V Kolykhalov,E V Ponomareva,Ya B Fedorova,N D Selezneva

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova（2018）

引用 10|浏览6

暂无评分

摘要

The drug is well-tolerated and safe and can be recommended for preventive treatment of dementia in patients with high AD risk, in particular in elderly patients with aMCI syndrome.

查看译文

关键词

choline alphoscerate,mild cognitive impairment,therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要